118th Congress · HOUSE BILLBILL

H.R. 7709PREPARE ACT of 2024

To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production.

Health
Introduced Mar 15, 2024
Last action Mar 22, 2024
Pipeline · Bill → Law
Step 1
Introduced
Mar 15, 2024
Step 2
Referred
Mar 22, 2024
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill establishes the Strategic Active Pharmaceutical Ingredient Reserve. The Department of Health and Human Services (HHS) must annually publish a public list of essential generic medicines that are medically necessary to have available at all times. HHS must report and implement a plan to establish the reserve, which must be designed to minimize the impact of an interruption or reduction in imports of (1) key starting materials (including active pharmaceutical ingredients) for essential generic medicines, and (2) finished dosage forms of essential generic medicines for which key starting materials are not imported. The plan must also contain provisions to strengthen domestic capacity...

Provisions · 5 sectionsIntroduced in House
Timeline · 3 actions
Mar 22, 2024
Referred to the Subcommittee on Health.
Mar 15, 2024
Introduced in House
Mar 15, 2024
Referred to the House Committee on Energy and Commerce.